Product Information

LEXAPRO 5 MG TABLET is a brand product labeled by Allergan, Inc., priced at $14.7432 per EA under NDC 00456200501. Its NADAC has been published 663 times since Nov 28, 2013.

FDA first approved this application on Aug 14, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the ESCITALOPRAM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LEXAPRO 5 MG TABLET

ESCITALOPRAM
$14.7432per EA
High Outlier

Strength

5 mg/1

Manufacturer

Allergan, Inc.

NDC

00456200501

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

1/2/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

New Drug (NDA)

FDA Application

NDA021323

FDA Approved

8/14/2002

TE Code

AB

On Market Since

8/14/2002

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for LEXAPRO 5 MG TABLET has been published 663 times since Nov 28, 2013, and over the history we have for it it has risen 204.6%. The table below summarizes its recorded NADAC range and movement.

Current price$14.7432 per EA
All-time high$14.7432 (Aug 19, 2026)
All-time low$4.8405 (Nov 28, 2013)
52-week high$14.7432
52-week low$14.0263
Median price$11.2408
Average price$10.6042
Largest weekly change+11.0% (Jul 8, 2015)
Weeks tracked663
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+5.1%

3Y

+13.3%

5Y

+24.9%

All

+204.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ESCITALOPRAM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LEXAPRO 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEXAPRO 5 MG TABLET, manufactured by Allergan, Inc., is $14.7432 per EA (NDC 00456200501), effective Aug 19, 2026.

How has the price of LEXAPRO 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEXAPRO 5 MG TABLET has risen 204.6%. It has been tracked across 663 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEXAPRO 5 MG TABLET?

Since Nov 28, 2013, the NADAC for LEXAPRO 5 MG TABLET has ranged from a low of $4.8405 (Nov 28, 2013) to a high of $14.7432 (Aug 19, 2026), with a median of $11.2408 per EA.

Are there cheaper alternatives to LEXAPRO 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of LEXAPRO 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LEXAPRO 5 MG TABLET?

LEXAPRO 5 MG TABLET (NDC 00456200501) is labeled by Allergan, Inc., and CMS classifies it as a brand product.